Patients News | pharmaphorum

News

BMS’ Sotyktu cleared for NHS use in psoriasis

Just a few weeks after its approval in the UK, Bristol-Myers Squibb’s new oral psoriasis therapy Sotyktu has been recommended for routine NHS in England and Wales.

News

FDA approves first cell therapy for type 1 diabetes

CellTrans has claimed the first FDA approval for a cell therapy used to treat type 1 diabetes, consisting of insulin-producing islet beta cells taken from deceased donors.

News

AstraZeneca pledges $400m to fight deforestation

AstraZeneca has said it will plant 200 million trees across six continents by 2030 in an effort to fight escalating rates of deforestation around the globe that is contrib

News

DexCare raises $75m for digital patient booking system

DexCare has topped up its finances with a $75 million third round that will be used to fund the continued roll-out of its patient appointment booking platform.

News

NHS a laggard on patient outcomes, says think tank

The UK is falling behind many of its peers on healthcare outcomes, including life expectancy and avoidable deaths, according to a new study.

News

CMS sheds light on its registry plan for Alzheimer’s drugs

The Centers for Medicare and Medicaid Services (CMS) in the US has provided more details about the controversial plan to require participation in a patient registry as a c

BMS’ Sotyktu cleared for NHS use in psoriasis

FDA approves first cell therapy for type 1 diabetes

AstraZeneca pledges $400m to fight deforestation

DexCare raises $75m for digital patient booking system

NHS a laggard on patient outcomes, says think tank

CMS sheds light on its registry plan for Alzheimer’s drugs

Lundbeck preps phase 3 for migraine prevention drug

How to meet your physicians where they are online

News

Editor's Picks